HANS BIOMED CORPORATION

042520 KRX Pharmaceuticals Pharmaceuticals
KOSDAQ
₩19,730.00
-1.84%
Delayed · cached 15 min
Fair Value Analysis →

Frequently asked questions

What sector does HANS BIOMED CORPORATION belong to?
HANS BIOMED CORPORATION operates in the Pharmaceuticals sector, specifically the Pharmaceuticals industry, and is listed on the US markets.
What is the current share price of 042520?
As of the latest available quote, 042520 traded at ₩19,730.00. This price is delayed and cached for about 15 minutes.
What is the market capitalisation of 042520?
The market capitalisation of HANS BIOMED CORPORATION is approximately ₩262.26B.
Is HANS BIOMED CORPORATION profitable?
For its latest reported financial year, HANS BIOMED CORPORATION recorded a negative net profit margin of about -35.73% (a net loss for the latest period).
What is the return on equity (ROE) of 042520?
HANS BIOMED CORPORATION has a return on equity (ROE) of about -92.99%. ROE measures how much profit a company generates relative to shareholders' equity.

These answers are generated from reported financial data and live market figures, for educational and informational purposes only.

Educational data only. Not a recommendation to buy, sell or hold any security.